Skip to content

A prospective randomized controlled trial to evaluate two approaches for EEG application on the incidence of electrode-induced skin injury among ambulatory EEG patients

A Prospective Randomized Controlled trial of a mixed electrode (standard + hydrogel) approach to EEG application versus a standard approach (standard electrodes only), to the incidence of electrode-induced skin injury among ambulatory EEG patients

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620001157965
Enrollment
79
Registered
2020-11-04
Start date
2020-11-23
Completion date
2021-05-31
Last updated
2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is a prospective randomized controlled trial to evaluate two approaches to reducing EEG electrode induced skin injury among ambulatory EEG patients. The trial is to compare skin injury related to EEG electrode application using Ten-20 paste with Tensive adhesive gel versus mixed EEG electrodes with hydrogel electrodes Research Questions are: i) Is a mixed approach to EEG electrode application (one which uses hydrogel electrodes in hairless scalp locations), a superior approach to reducing electrode-related skin injury than the standard approach across all scalp locations, among patients undergoing ambulatory EEG monitoring? ii) Does the use of the novel mixed EEG electrode approach yield equivocal quality EEG recording data and self-reported patient satisfaction when compared with the standard approach? We hope that our research will continue contributing to the development of an evidence base on the prevention and minimization of electrode-induced skin injury in the patients undergoing AEEG monitoring.

Interventions

Aim: To compare skin injury related to EEG electrode application using Ten 20 paste with Tensive adhesive gel versus mixed EEG electrodes with hydrogel electrodes. A prospective, randomized controlled intervention study will be conducted: From November 2020 to May 2021 in the Ambulatory Care Unit at Royal Prince Alfred Hospital. Following attendance at the clinic, patients will be randomized into two groups. Group 1 (Standard Care Group) will receive standard electrodes affixed with Ten-20

Aim: To compare skin injury related to EEG electrode application using Ten 20 paste with Tensive adhesive gel versus mixed EEG electrodes with hydrogel electrodes. A prospective, randomized controlled intervention study will be conducted: From November 2020 to May 2021 in the Ambulatory Care Unit at Royal Prince Alfred Hospital. Following attendance at the clinic, patients will be randomized into two groups. Group 1 (Standard Care Group) will receive standard electrodes affixed with Ten-20 conductive paste with tensive adhesive gel. Group 2 (Active Care Group) will receive Ten-20 conductive paste with tensive adhesive gel mixed with the use of hydrogel electrodes in frontal and hairless regions on the scalp. All patients will be monitored for four days. They will be required to attend the Neuroscience Ambulatory Care Unit twice after the application of EEG electrodes: i) post-application of EEG (day 2): 30 minutes for changing batteries and checking the electrodes placement ii) on EEG electrodes removal day (day 4): 30minutes for removing the electrodes, answering the survey; taking the pictures of the scalp The patients are required to return to the clinic on the day 2 post application for changing batteries, checking the replacement, and repositioning of the electrodes repositioning of the frontal pole electrodes (Fp1 & Fp2) for the group 1. The frontal electrodes in Group 2 are not removed unless there is dislodgement. The nurses will assess their scalps before application of EEG electrodes. When they return on EEG removal day (day 4), the nurses will remove all EEG electrodes and will take pictures of their scalps. The nurse will also ask them to complete a self-report questionnaire for evaluating the tolerability of ambulatory EEG monitoring. This questionnaire will take you 5 minutes to complete. All patients will be required to return the clinic any time during their home monitoring if the recording device turns off or electrode dislodgements occur. Two trained neurophysiology nurses will assess consecutive patients. One nurse will complete the pre-application assessment form while the other nurse will apply the EEG electrodes. The nurses will assess the skin condition at the 23 EEG electrode sites on the day of electrode removal (day4) and take digital photographs of the scalp of the patients. A nurse who is not involved in the EEG application process will complete the skin assessment tool in a blinded fashion by reviewing un-notated photographs only. This nurse will have no knowledge of the intervention allocation schedule, which will be maintained by the study nurses. All the nurses who will be involved in performing ambulatory EEG testing will receive training about the study protocol before commencing the research. We will outline a step-by-step process in performing the AEEG testing, to be best positioned to have uniformity in preparing the skin and performing the test. A training log for the nurses who will be performing the test will be maintained.

Sponsors

Royal Prince Alfred Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

All patients are eligible for this study if they are older than 18 years of age and have valid neurologist referrals for AEEG monitoring for four days.

Exclusion criteria

* Patients have skin irritation/inflammation or headlice on their scalp; * Patients are allergic to Ten-20 conductive paste, Tensive gel or hydrogel; * Patients are confused or agitated; * Patients are unable to tolerate AEEG monitoring; * Patients are less than 18 or more than 90 years of age.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026